TCRX
TScan Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.39
+5.55%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-60.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 22, 2026 | Klencke Barbara · director | A-Award | 67,000 | $0.99 |
| May 22, 2026 | Gruia Gabriela · director | A-Award | 67,000 | $0.99 |
| May 22, 2026 | Nicholson Garry A · director | A-Award | 67,000 | $0.99 |
| May 22, 2026 | Woods Keith · director | A-Award | 67,000 | $0.99 |
| May 22, 2026 | BAKER BROS. ADVISORS LP · director | A-Award | 67,000 | $0.99 |
| May 22, 2026 | Dorton Katina · director | A-Award | 67,000 | $0.99 |
| Jan 22, 2026 | Louis Chrystal · officer: Chief Medical Officer | A-Award | 420,000 | $1.12 |
| Jan 22, 2026 | ZDRAVESKI ZORAN · officer: See Remarks | A-Award | 350,000 | $1.12 |
| Jan 22, 2026 | Amello Jason · officer: Chief Financial Officer | A-Award | 350,000 | $1.12 |
| Jan 22, 2026 | MacBeath Gavin · director, officer: Chief Executive Officer | A-Award | 1,165,000 | $1.12 |
| Jan 22, 2026 | Dworak Leiden · officer: See Remarks | A-Award | 100,000 | $1.12 |
| Dec 23, 2025 | Lynx1 Capital Management LP · 10 percent owner | Purchase | 75,500 | $0.90 |
| Dec 23, 2025 | Lynx1 Capital Management LP · 10 percent owner | Purchase | 80,069 | $0.90 |
| Dec 23, 2025 | Lynx1 Capital Management LP · 10 percent owner | Purchase | 6,232 | $0.90 |
| Jul 2, 2025 | Dorton Katina · director | A-Award | 67,000 | $1.45 |
| Jul 2, 2025 | BAKER BROS. ADVISORS LP · director | A-Award | 67,000 | $1.45 |
| Jul 2, 2025 | Gruia Gabriela · director | A-Award | 67,000 | $1.45 |
| Jul 2, 2025 | Klencke Barbara · director | A-Award | 67,000 | $1.45 |
| Jul 2, 2025 | Nicholson Garry A · director | A-Award | 67,000 | $1.45 |
| Jul 2, 2025 | Woods Keith · director | A-Award | 67,000 | $1.45 |
| May 21, 2025 | Lynx1 Capital Management LP · 10 percent owner | Purchase | 1,200,000 | $1.20 |
| May 21, 2025 | Lynx1 Capital Management LP · 10 percent owner | Purchase | 1,388,794 | $1.20 |
| Feb 11, 2025 | ZDRAVESKI ZORAN · officer: See Remarks | A-Award | 250,000 | $3.06 |
| Feb 11, 2025 | MacBeath Gavin · director, officer: Chief Executive Officer | A-Award | 160,000 | $6.00 |
| Feb 11, 2025 | MacBeath Gavin · director, officer: Chief Executive Officer | A-Award | 800,000 | $3.06 |
| Feb 11, 2025 | Dworak Leiden · other: Vice President, Finance | A-Award | 46,875 | $6.00 |
| Feb 11, 2025 | ZDRAVESKI ZORAN · officer: See Remarks | A-Award | 52,500 | $6.00 |
| Feb 11, 2025 | Louis Chrystal · officer: Chief Medical Officer | A-Award | 400,000 | $3.06 |
| Feb 11, 2025 | Amello Jason · officer: Chief Financial Officer | A-Award | 270,000 | $3.06 |
| Dec 30, 2024 | Lynx1 Capital Management LP · 10 percent owner | Purchase | 7,500,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 11Increased 16Reduced 22Sold out 59
| Filer | Action | Shares | Filed |
|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | Unchanged | 8,019,148 | May 4, 2026 |
| BVF INC/IL | Increased | 5,564,290 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 2,784,792 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,154,256 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 1,840,952 | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 1,460,285 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 1,364,783 | May 14, 2026 |
| DEER MANAGEMENT CO. LLC | Unchanged | 1,245,504 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 1,209,009 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,009,107 | Sep 2, 2026 |
| ABRDN PLC | Reduced | 918,020 | Apr 29, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Increased | 808,356 | May 15, 2026 |
| DC FUNDS, LP | Unchanged | 630,000 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 616,952 | May 15, 2026 |
| GSA CAPITAL PARTNERS LLP | Increased | 378,960 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 22, 2026